GLENMARK PHARMA (GLENMARK) - Live BSE, NSE Stock Quotes - GLENMARK PHARMA Analysis Update - Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA   (GLPH)

REFRESH
Live BSE Quotes Aug 24, 2016 12:09:00 PM
Price (Rs)856.60 Open (Rs) 850.00 High (Rs) 864.40 Low (Rs) 849.55
% Change0.95 Volume 12,145 Value (Rs) 10,403,407 52-Week H/L 1,229.25 / 671.50
Live NSE Quotes Aug 24, 2016 12:09:52 PM
Price (Rs)856.35 Open (Rs) 852.00 High (Rs) 865.00 Low (Rs) 847.00
% Change0.90 Volume 226,488 Value (Rs) 194,528,278 52-Week H/L 1,234.90 / 671.10
Valuation
EPS (Rs)* 28.33 P/E Ratio (x) 30.23 Market Cap (Rs m) 232,378.45 P/BV (x) 7.75
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
GLENMARK PHARMA Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new

Related Views On News

Glenmark: Margins under Pressure (Quarterly Results Update - Detailed)

Jun 22, 2016

Glenmark has announced its 4QFY16 results. The company has reported 30.5% YoY growth in sales and 1255.8% YoY increase in net profits. Here is our analysis of the results.

Glenmark: Emerging markets disappoint (Quarterly Results Update - Detailed)

Feb 5, 2016

Glenmark has announced its 3QFY16 results. The company has reported 4.5% YoY growth in sales and 48.3% YoY increase in net profits. Here is our analysis of the results.

Glenmark: Good quarter (Quarterly Results Update - Detailed)

Dec 21, 2015

Glenmark has announced its 2QFY16 results. The company has reported 13.4% YoY growth in sales and 19.8% YoY increase in net profits. Here is our analysis of the results.

Lupin: Niche products boost business growth (Quarterly Results Update - Detailed)

Jun 15, 2016

Lupin has announced its 4QFY16 results. Net sales have grown by 38.6% YoY, while net profits declined by 54.8% YoY. Here is our analysis of the results.

Cipla: Impacted by one offs (Quarterly Results Update - Detailed)

Jun 2, 2016

Cipla has announced its 4QFY16 results. The company has reported 7.6% YoY growth in sales and a decline of 68.9% YoY in net profits. Here is our analysis of the results.

More Views on News

Most Popular

Don't Fight Easy Money(Daily Profit Hunter)

Aug 12, 2016

Don't fight easy money. It is better to focus your efforts on profiting from market trends, instead of trying to explain or criticise them

Why Do People Still Have Deposits in Indian Overseas Bank and UCO Bank?(Vivek Kaul's Diary)

Aug 16, 2016

The bad loans of these banks now make up for close to one-fifth of their lending.

High-Growth Stocks: Are You Paying for Sprinters or Marathoners?(The 5 Minute Wrapup)

Aug 12, 2016

Here's how to think about valuations of Usain Bolt-like fast running businesses.

Will RBI remain Independent?(The Honest Truth)

Aug 16, 2016

The choice of next RBI governor could have a crucial impact on India's economic future.

Tech Funding Spree Coming to an End?(Chart Of The Day)

Aug 12, 2016

Why one needs to be extra cautious with flooding IPOs.

More

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - ADCOCK INGRAM COMPARISON

Compare Company With Charts

COMPARE GLENMARK PHARMA WITH

MARKET STATS